| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PRVAPrivia Health Group, Inc. | 2.93B | 23.86 | 216.91 | 4.74% | 0.89% | 2.38% | 3.55% | 0.01 |
| PGNYProgyny, Inc. | 2.1B | 24.31 | 42.65 | 7.22% | 4.46% | 10.1% | 8.29% | 0.05 |
| DOCSDoximity, Inc. | 5.64B | 41.05 | 36.98 | 19.98% | 40.72% | 23.1% | 4.73% | 0.01 |
| HSTMHealthStream, Inc. | 653.89M | 22.04 | 33.39 | 4.51% | 6.93% | 5.93% | 4.51% | 0.06 |
| SPOKSpok Holdings, Inc. | 272.51M | 13.23 | 18.12 | -0.99% | 11.88% | 11.16% | 9.44% | 0.06 |
| BTSGBrightSpring Health Services, Inc. Common Stock | 7.14B | 39.60 | -423.08 | 27.65% | 1.04% | 7.12% | 1.76 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 4.53B | 5.58B | 6.7B | 7.72B | 8.83B | 11.27B |
| Revenue Growth % | - | 0.23% | 0.2% | 0.15% | 0.14% | 0.28% |
| Cost of Goods Sold | 3.69B | 4.53B | 5.45B | 6.37B | 7.39B | 9.68B |
| COGS % of Revenue | 0.82% | 0.81% | 0.81% | 0.82% | 0.84% | 0.86% |
| Gross Profit | 833.91M | 1.05B | 1.25B | 1.35B | 1.43B | 1.59B |
| Gross Margin % | 0.18% | 0.19% | 0.19% | 0.18% | 0.16% | 0.14% |
| Gross Profit Growth % | - | 0.26% | 0.19% | 0.08% | 0.06% | 0.11% |
| Operating Expenses | 770.59M | 883.55M | 1.01B | 1.17B | 1.29B | 1.38B |
| OpEx % of Revenue | 0.17% | 0.16% | 0.15% | 0.15% | 0.15% | 0.12% |
| Selling, General & Admin | 770.59M | 883.55M | 1.01B | 1.13B | 1.29B | 1.38B |
| SG&A % of Revenue | 0.17% | 0.16% | 0.15% | 0.15% | 0.15% | 0.12% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 40.86M | 0 | 0 |
| Operating Income | 63.31M | 165.19M | 234.18M | 187.83M | 147.18M | 206.37M |
| Operating Margin % | 0.01% | 0.03% | 0.03% | 0.02% | 0.02% | 0.02% |
| Operating Income Growth % | - | 1.61% | 0.42% | -0.2% | -0.22% | 0.4% |
| EBITDA | 218.18M | 346.69M | 433.34M | 391.8M | 349.52M | 410.86M |
| EBITDA Margin % | 0.05% | 0.06% | 0.06% | 0.05% | 0.04% | 0.04% |
| EBITDA Growth % | - | 0.59% | 0.25% | -0.1% | -0.11% | 0.18% |
| D&A (Non-Cash Add-back) | 154.87M | 181.5M | 199.16M | 203.97M | 202.34M | 204.48M |
| EBIT | 63.31M | 165.19M | 234.18M | 187.83M | 147.18M | 193.65M |
| Net Interest Income | -166.89M | -138.95M | -165.32M | -233.58M | -324.59M | -228.39M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 166.89M | 138.95M | 165.32M | 233.58M | 324.59M | 228.39M |
| Other Income/Expense | -166.89M | -138.95M | -165.32M | -233.58M | -324.59M | -241.11M |
| Pretax Income | -103.58M | 26.24M | 68.86M | -45.75M | -177.41M | -34.74M |
| Pretax Margin % | -0.02% | 0% | 0.01% | -0.01% | -0.02% | -0% |
| Income Tax | -32.49M | 5.09M | 17.6M | 8.46M | -20.58M | -14.22M |
| Effective Tax Rate % | 0.7% | 0.79% | 0.72% | 1.18% | 0.87% | 0.52% |
| Net Income | -72.38M | 20.81M | 49.8M | -53.91M | -154.6M | -18.06M |
| Net Margin % | -0.02% | 0% | 0.01% | -0.01% | -0.02% | -0% |
| Net Income Growth % | - | 1.29% | 1.39% | -2.08% | -1.87% | 0.88% |
| Net Income (Continuing) | -71.09M | 21.15M | 51.26M | -54.22M | -156.84M | -20.52M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 53.36M | 30.39M | 25.65M | 29.31M | 27.81M | 3.73M |
| EPS (Diluted) | -0.42 | 0.12 | 0.29 | -0.31 | -0.90 | -0.09 |
| EPS Growth % | - | 1.29% | 1.42% | -2.07% | -1.9% | 0.9% |
| EPS (Basic) | -0.42 | 0.12 | 0.29 | -0.31 | -0.90 | -0.09 |
| Diluted Shares Outstanding | 171.19M | 171.19M | 171.19M | 171.19M | 171.19M | 193M |
| Basic Shares Outstanding | 171.19M | 171.19M | 171.19M | 171.19M | 171.19M | 193M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 870.68M | 1.29B | 1.18B | 1.34B | 1.46B | 1.89B |
| Cash & Short-Term Investments | 18.3M | 262M | 46.73M | 13.63M | 13.07M | 61.25M |
| Cash Only | 18.3M | 262M | 46.73M | 13.63M | 13.07M | 61.25M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 622.28M | 700.84M | 805M | 868.35M | 1.01B | 1.15B |
| Days Sales Outstanding | 50.19 | 45.84 | 43.87 | 41.05 | 41.8 | 37.23 |
| Inventory | 198.47M | 300.06M | 299.22M | 430.52M | 402.78M | 640.57M |
| Days Inventory Outstanding | 19.63 | 24.17 | 20.04 | 24.68 | 19.89 | 24.16 |
| Other Current Assets | 23.37M | 16.41M | 12.66M | 13.51M | 13.19M | 24.59M |
| Total Non-Current Assets | 2.95B | 3.25B | 4.33B | 4.1B | 4.08B | 4.03B |
| Property, Plant & Equipment | 432.55M | 450.71M | 524.64M | 475.27M | 513.35M | 500.03M |
| Fixed Asset Turnover | 10.46x | 12.38x | 12.77x | 16.24x | 17.19x | 22.53x |
| Goodwill | 1.41B | 1.67B | 2.66B | 2.58B | 2.61B | 2.67B |
| Intangible Assets | 1.07B | 1.1B | 1.11B | 975.86M | 881.48M | 811.48M |
| Long-Term Investments | 2.37M | 2.48M | 2.66M | 736K | 720K | 670K |
| Other Non-Current Assets | 34.56M | 32.22M | 35.78M | 68.93M | 72.12M | 43.8M |
| Total Assets | 3.82B | 4.54B | 5.51B | 5.44B | 5.53B | 5.93B |
| Asset Turnover | 1.19x | 1.23x | 1.21x | 1.42x | 1.60x | 1.90x |
| Asset Growth % | - | 0.19% | 0.21% | -0.01% | 0.02% | 0.07% |
| Total Current Liabilities | 621.97M | 742.79M | 892.16M | 932.51M | 1.25B | 1.43B |
| Accounts Payable | 252.75M | 355.75M | 408.11M | 526.92M | 641.61M | 941.29M |
| Days Payables Outstanding | 24.99 | 28.65 | 27.33 | 30.21 | 31.68 | 35.5 |
| Short-Term Debt | 18.48M | 22.5M | 40.54M | 30.41M | 32.27M | 48.73M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 14.19M | 16.18M | 95.87M | 80.73M | 118.14M | 98.84M |
| Current Ratio | 1.40x | 1.74x | 1.32x | 1.44x | 1.17x | 1.33x |
| Quick Ratio | 1.08x | 1.33x | 0.99x | 0.98x | 0.84x | 0.88x |
| Cash Conversion Cycle | 44.83 | 41.35 | 36.57 | 35.53 | 30.01 | 25.89 |
| Total Non-Current Liabilities | 2.49B | 3.06B | 3.82B | 3.72B | 3.67B | 2.85B |
| Long-Term Debt | 2.16B | 2.67B | 3.39B | 3.36B | 3.33B | 2.56B |
| Capital Lease Obligations | 190.15M | 211.95M | 252.09M | 204.91M | 224.18M | 212.6M |
| Deferred Tax Liabilities | 65.68M | 121.64M | 98.16M | 79.39M | 23.67M | 0 |
| Other Non-Current Liabilities | 65.46M | 57.98M | 77.04M | 75.94M | 91.94M | 71.76M |
| Total Liabilities | 3.11B | 3.81B | 4.71B | 4.66B | 4.92B | 4.27B |
| Total Debt | 2.44B | 2.97B | 3.77B | 3.68B | 3.67B | 2.9B |
| Net Debt | 2.43B | 2.71B | 3.72B | 3.66B | 3.66B | 2.84B |
| Debt / Equity | 3.44x | 4.04x | 4.71x | 4.69x | 5.99x | 1.76x |
| Debt / EBITDA | 11.20x | 8.58x | 8.70x | 9.39x | 10.50x | 7.07x |
| Net Debt / EBITDA | 11.12x | 7.82x | 8.59x | 9.35x | 10.46x | 6.92x |
| Interest Coverage | 0.38x | 1.19x | 1.42x | 0.80x | 0.45x | 0.90x |
| Total Equity | 710.23M | 735.38M | 800.46M | 784.08M | 612.55M | 1.65B |
| Equity Growth % | - | 0.04% | 0.09% | -0.02% | -0.22% | 1.7% |
| Book Value per Share | 4.15 | 4.30 | 4.68 | 4.58 | 3.58 | 8.56 |
| Total Shareholders' Equity | 656.87M | 704.98M | 774.82M | 754.78M | 584.74M | 1.65B |
| Common Stock | 745.88M | 745.17M | 1.18M | 1.18M | 1.18M | 1.74M |
| Retained Earnings | -94.28M | -51.75M | 971K | -45.72M | -200.32M | -222.16M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 132K | 185K | 217K | 21.19M | 12.54M | 1.42M |
| Minority Interest | 53.36M | 30.39M | 25.65M | 29.31M | 27.81M | 3.73M |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 110.91M | 222.64M | 270.17M | -4.65M | 210.78M | 23.77M |
| Operating CF Margin % | 0.02% | 0.04% | 0.04% | -0% | 0.02% | 0% |
| Operating CF Growth % | - | 1.01% | 0.21% | -1.02% | 46.3% | -0.89% |
| Net Income | -71.09M | 20.81M | 49.8M | -54.22M | -156.84M | -20.52M |
| Depreciation & Amortization | 154.87M | 181.5M | 199.16M | 203.97M | 202.34M | 204.48M |
| Stock-Based Compensation | 3.71M | 6.27M | 4.52M | 3.55M | 3.92M | 69.17M |
| Deferred Taxes | -34.41M | 22.6M | 6.49M | -27.96M | -52.63M | 0 |
| Other Non-Cash Items | 64.31M | 27.54M | 40.31M | 94.48M | 54.56M | 40.71M |
| Working Capital Changes | -6.48M | -36.08M | -30.11M | -224.47M | 159.44M | -270.07M |
| Change in Receivables | -53.95M | -58.91M | -93M | -150.47M | -127.25M | -179.04M |
| Change in Inventory | -16.03M | -95.73M | 4.29M | -131.83M | 28.66M | -236.51M |
| Change in Payables | 46.78M | 100.43M | 63.54M | 133.47M | 105.65M | 303.21M |
| Cash from Investing | -1.53B | -451.85M | -1.19B | 45.36M | -134.43M | -140.24M |
| Capital Expenditures | -51.22M | -51.91M | -59.27M | -70.11M | -73.53M | -80.91M |
| CapEx % of Revenue | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 1.41M | 1.05M | 1.7M | 2.13M | 2.15M | 473K |
| Cash from Financing | 1.41B | 472.92M | 705.22M | -73.81M | -76.91M | 164.65M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -118.59M | -19.12M | -34.03M | -4.88M | -10.12M | -50.83M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | 59.69M | 170.73M | 210.9M | -74.77M | 137.26M | -57.14M |
| FCF Margin % | 0.01% | 0.03% | 0.03% | -0.01% | 0.02% | -0.01% |
| FCF Growth % | - | 1.86% | 0.24% | -1.35% | 2.84% | -1.42% |
| FCF per Share | 0.35 | 1.00 | 1.23 | -0.44 | 0.80 | -0.30 |
| FCF Conversion (FCF/Net Income) | -1.53x | 10.70x | 5.43x | 0.09x | -1.36x | -1.32x |
| Interest Paid | 134.38M | 129.57M | 0 | 213.31M | 303.53M | 211.39M |
| Taxes Paid | 3.72M | 3M | 0 | 28.85M | 37.5M | 24.95M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -10.19% | 2.88% | 6.48% | -6.8% | -22.14% | -1.6% |
| Return on Invested Capital (ROIC) | 1.51% | 3.76% | 4.41% | 3.14% | 2.53% | 3.53% |
| Gross Margin | 18.43% | 18.79% | 18.64% | 17.54% | 16.24% | 14.1% |
| Net Margin | -1.6% | 0.37% | 0.74% | -0.7% | -1.75% | -0.16% |
| Debt / Equity | 3.44x | 4.04x | 4.71x | 4.69x | 5.99x | 1.76x |
| Interest Coverage | 0.38x | 1.19x | 1.42x | 0.80x | 0.45x | 0.90x |
| FCF Conversion | -1.53x | 10.70x | 5.43x | 0.09x | -1.36x | -1.32x |
| Revenue Growth | - | 23.32% | 20.03% | 15.27% | 14.32% | 27.65% |
| 2024 | |
|---|---|
| Commercial Insurance | 2.56B |
| Commercial Insurance Growth | - |
| Medicaid | 2.2B |
| Medicaid Growth | - |
BrightSpring Health Services, Inc. Common Stock (BTSG) reported $12.41B in revenue for fiscal year 2024. This represents a 174% increase from $4.53B in 2019.
BrightSpring Health Services, Inc. Common Stock (BTSG) grew revenue by 27.6% over the past year. This is strong growth.
Yes, BrightSpring Health Services, Inc. Common Stock (BTSG) is profitable, generating $129.6M in net income for fiscal year 2024 (-0.2% net margin).
BrightSpring Health Services, Inc. Common Stock (BTSG) has a return on equity (ROE) of -1.6%. Negative ROE indicates the company is unprofitable.
BrightSpring Health Services, Inc. Common Stock (BTSG) generated $276.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.